Home › HIV › North Carolina › Winston-Salem
HIV clinical trials in Winston-Salem, NC
5 studies for HIV are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Recruiting
- Wake Forest University, Implementation Science, Winston-Salem
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RecruitingPhase 3
- GSK Investigational Site, Winston-Salem
Project neuroARTEMIS
Recruiting
- Wake Forest University School of Medicine, Winston-Salem
Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older
Recruiting
- Atrium Health Wake Forest Baptist, Winston-Salem
Appalachian Partnership to Reduce Disparities (Aim 2)
RecruitingHealthy volunteers welcome
- Wake Forest University Health Sciences, Winston-Salem
About HIV
HIV (human immunodeficiency virus) attacks the body’s immune system. There is no cure but it can be treated with medicines. To know if you have HIV, get tested.
HIV trials in other cities
- Washington, DC22 studies
- New York City, NY19 studies
- Miami, FL17 studies
- Houston, TX17 studies
- Baltimore, MD16 studies
- San Francisco, CA15 studies
- Atlanta, GA14 studies
- Chicago, IL14 studies
- Boston, MA11 studies
- Philadelphia, PA11 studies
- San Diego, CA10 studies
- Los Angeles, CA9 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Breast Cancer14 studies
- Multiple Myeloma14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- Ovarian Cancer10 studies
- COPD9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Lung Cancer8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.